These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32910990)

  • 1. Acute depletion of telomerase components DKC1 and NOP10 induces oxidative stress and disrupts ribosomal biogenesis via NPM1 and activation of the P53 pathway.
    Ibáñez-Cabellos JS; Seco-Cervera M; Picher-Latorre C; Pérez-Machado G; García-Giménez JL; Pallardó FV
    Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118845. PubMed ID: 32910990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening.
    Ibáñez-Cabellos JS; Pérez-Machado G; Seco-Cervera M; Berenguer-Pascual E; García-Giménez JL; Pallardó FV
    Redox Biol; 2018 Apr; 14():398-408. PubMed ID: 29055871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.
    Carrillo J; González A; Manguán-García C; Pintado-Berninches L; Perona R
    Clin Transl Oncol; 2014 Jun; 16(6):529-38. PubMed ID: 24065372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudouridylation defect due to
    Balogh E; Chandler JC; Varga M; Tahoun M; Menyhárd DK; Schay G; Goncalves T; Hamar R; Légrádi R; Szekeres Á; Gribouval O; Kleta R; Stanescu H; Bockenhauer D; Kerti A; Williams H; Kinsler V; Di WL; Curtis D; Kolatsi-Joannou M; Hammid H; Szőcs A; Perczel K; Maka E; Toldi G; Sava F; Arrondel C; Kardos M; Fintha A; Hossain A; D'Arco F; Kaliakatsos M; Koeglmeier J; Mifsud W; Moosajee M; Faro A; Jávorszky E; Rudas G; Saied MH; Marzouk S; Kelen K; Götze J; Reusz G; Tulassay T; Dragon F; Mollet G; Motameny S; Thiele H; Dorval G; Nürnberg P; Perczel A; Szabó AJ; Long DA; Tomita K; Antignac C; Waters AM; Tory K
    Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15137-15147. PubMed ID: 32554502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.
    Walne AJ; Vulliamy T; Marrone A; Beswick R; Kirwan M; Masunari Y; Al-Qurashi FH; Aljurf M; Dokal I
    Hum Mol Genet; 2007 Jul; 16(13):1619-29. PubMed ID: 17507419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the understanding of dyskeratosis congenita.
    Walne AJ; Dokal I
    Br J Haematol; 2009 Apr; 145(2):164-72. PubMed ID: 19208095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
    Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
    Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
    Vulliamy TJ; Dokal I
    Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
    Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
    PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A zebrafish model of dyskeratosis congenita reveals hematopoietic stem cell formation failure resulting from ribosomal protein-mediated p53 stabilization.
    Pereboom TC; van Weele LJ; Bondt A; MacInnes AW
    Blood; 2011 Nov; 118(20):5458-65. PubMed ID: 21921046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dyskeratosis congenita mutations in dyskerin, NHP2 and NOP10 on assembly of H/ACA pre-RNPs.
    Trahan C; Martel C; Dragon F
    Hum Mol Genet; 2010 Mar; 19(5):825-36. PubMed ID: 20008900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing.
    Zhang Y; Morimoto K; Danilova N; Zhang B; Lin S
    PLoS One; 2012; 7(1):e30188. PubMed ID: 22299032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
    Donaires FS; Alves-Paiva RM; Gutierrez-Rodrigues F; da Silva FB; Tellechea MF; Moreira LF; Santana BA; Traina F; Dunbar CE; Winkler T; Calado RT
    Stem Cell Res; 2019 Oct; 40():101540. PubMed ID: 31479877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.
    Carrillo J; Martínez P; Solera J; Moratilla C; González A; Manguán-García C; Aymerich M; Canal L; Del Campo M; Dapena JL; Escoda L; García-Sagredo JM; Martín-Sala S; Rives S; Sevilla J; Sastre L; Perona R
    Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):140-6. PubMed ID: 22664374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and genetic features of dyskeratosis congenital with bone marrow failure in eight patients].
    Wan Y; An WB; Zhang JY; Zhang JL; Zhang RR; Zhu S; Chang LX; Zhang YC; Liu F; Yang WY; Chen XJ; Zou Y; Chen YM; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):216-20. PubMed ID: 27033759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dyskeratosis congenita, a disease caused by defective telomere maintenance].
    Hoareau-Aveilla C; Henry Y; Leblanc T
    Med Sci (Paris); 2008 Apr; 24(4):390-8. PubMed ID: 18405638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyskeratosis congenita: a disorder of defective telomere maintenance?
    Walne AJ; Marrone A; Dokal I
    Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyskeratosis congenita as a disorder of telomere maintenance.
    Nelson ND; Bertuch AA
    Mutat Res; 2012 Feb; 730(1-2):43-51. PubMed ID: 21745483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mutations in TERT, the genes for telomerase reverse transcriptase, in Indian patients of aplastic anaemia: a pilot study.
    Mehta S; Krishnamohan M; Gulati S; Sharmat N; Vashishtha P; Singh I
    J Assoc Physicians India; 2014 Oct; 62(10):13-7. PubMed ID: 25906515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.